Loading organizations...
OKG Capital provides venture capital to early-stage Med-Tech and Life Science companies, fostering advancements in medical technology, pharmaceuticals, and biological research. The fund identifies promising ventures, aiding their maturation from initial concepts into market-ready solutions. Their investment strategy is geared toward propelling growth within these critical sectors.
Principal figures at OKG Capital include Gabor Zichy, an industrial designer with mechanical engineering expertise, alongside Karim Galzahr, Ines Galzahr, and Sol Jordan. While specific founding details remain unpublicized, their collective background suggests a deliberate commitment to fostering scientific and technological innovation in critical healthcare, informing their investment thesis.
OKG Capital serves nascent Med-Tech and Life Science companies seeking foundational capital and strategic support. Its long-term vision translates pioneering scientific discoveries into tangible global health improvements. The firm aims to cultivate a portfolio of innovative companies, contributing to a technologically advanced, healthier future.
OKG Investments has 1 tracked investment across 1 company. The latest tracked deal is $65.0M Series A in Unstoppable Domains in July 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2022 | Unstoppable Domains | $65.0M Series A | Pantera Capital | Aviondor Group (south Fund, LP), Collab+Currency, Infinite Niches, Pareto Holdings, Rainfall Ventures, Adam Goldstein, Andrew Rosener, Alchemy Ventures, Boost VC, Broadhaven, CoinDCX Ventures, CoinGecko, Draper Associates, EI Ventures, Gaingels, Hard Yaka, Mayfield, Polygon Labs, RED Beard Ventures, Spartan Group, WE3 Syndicate |
